Patents Assigned to ALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS, INC.
  • Patent number: 11717525
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: August 8, 2023
    Assignee: Alpha To Omega Pharmaceutical Consultants, Inc.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi
  • Patent number: 10624901
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: April 21, 2020
    Assignee: Alpha to Omega Pharmaceutical Consultants, Inc.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi
  • Patent number: 10500196
    Abstract: Pharmaceutical compositions for simultaneous transdermal delivery of Doxylamine and Pyridoxine comprising Doxylamine or its salts, Pyridoxine or its salts or its active metabolites and a vehicle system wherein pharmaceutical compositions are liquid formulations, semisolid formulations and polymer matrices. Further pharmaceutical compositions can be incorporated into transdermal delivery systems or transdermal patches. The invention provides a method for treatment of nausea and vomiting in general, and for pregnant women in particular by continuous and simultaneous transdermal delivery of Doxylamine and Pyridoxine. This is to be accomplished through topical application of pharmaceutical compositions or by application of a transdermal delivery system or transdermal patch to the surface of the skin wherein the duration of application is once in a day, once every two days, once every three days, once every four days, once every five days, once every six days, or once in a week.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: December 10, 2019
    Assignee: Alpha To Omega Pharmaceutical Consultants, Inc.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Tamanna Lather, Marina Borovinskaya
  • Patent number: 10449201
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: October 22, 2019
    Assignee: ALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS, INC.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi